000			01922 a2200529 4500
005			20250517012359.0
264		0	_c20150501
008			201505s 0 0 eng d
022			_a1532-1827
024	7		_a10.1038/bjc.2014.647 _2doi
040			_aNLM _beng _cNLM
100	1		_aGonzalez-Angulo, A M
245	0	0	_aEffect of adjuvant trastuzumab among patients treated with anti-HER2-based neoadjuvant therapy. _h[electronic resource]
260			_bBritish journal of cancer _cFeb 2015
300			_a630-5 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntibodies, Monoclonal, Humanized _xtherapeutic use
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aCarcinoma, Ductal, Breast _xdrug therapy
650	0	4	_aChemotherapy, Adjuvant
650	0	4	_aCyclophosphamide _xadministration & dosage
650	0	4	_aEpirubicin _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aFluorouracil _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aMiddle Aged
650	0	4	_aNeoadjuvant Therapy
650	0	4	_aPaclitaxel _xadministration & dosage
650	0	4	_aProtein Kinase Inhibitors _xadministration & dosage
650	0	4	_aReceptor, ErbB-2 _xantagonists & inhibitors
650	0	4	_aRetrospective Studies
650	0	4	_aTrastuzumab
700	1		_aParinyanitikul, N
700	1		_aLei, X
700	1		_aMittendorf, E A
700	1		_aZhang, H
700	1		_aValero, V
700	1		_aHunt, K K
700	1		_aHortobagyi, G N
700	1		_aChavez-MacGregor, M
773	0		_tBritish journal of cancer _gvol. 112 _gno. 4 _gp. 630-5
856	4	0	_uhttps://doi.org/10.1038/bjc.2014.647 _zAvailable from publisher's website
999			_c24530003 _d24530003